홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Imidazole → 3-Ethyl-5-imidazol-1-yl-2-methoxy-6-methyl-pyridine

HRID 1921343
인쇄

반응식

HRID 1921343 반응식
Br[C:2]1[C:3]([CH3:12])=[N:4][C:5]([O:10][CH3:11])=[C:6]([CH2:8][CH3:9])[CH:7]=1.C(=O)([O-])[O-].[K+].[K+].[OH-].[Na+].[NH:21]1[CH:25]=[CH:24][N:23]=[CH:22]1>[Cu](I)I>[CH2:8]([C:6]1[C:5]([O:10][CH3:11])=[N:4][C:3]([CH3:12])=[C:2]([N:21]2[CH:25]=[CH:24][N:23]=[CH:22]2)[CH:7]=1)[CH3:9]
참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트

참가 물질

6

반응물 4

HCID 795ImidazoleHCID 11430Potassium CarbonateHCID 14798Sodium HydroxideHCID 116586693-Bromo-5-ethyl-6-methoxy-2-methylpyridine

생성물 1

HCID 674923193-Ethyl-5-imidazol-1-yl-2-methoxy-6-methyl-pyridine수율 28.1%

시약·촉매·용매 1

HCID 83717
Copper iodide
촉매

반응 조건

온도
185 °C

실험 절차

Into each of 2 microwave vials is added 3-bromo-5-ethyl-6-methoxy-2-methylpyridine (200 mg, 0.869 mmol), potassium carbonate (180 mg, 1.30 mmol), copper iodide (16 mg, 0.084 mmol), sodium hydroxide (84 mg, 2.10 mmol) and imidazole (59 mg, 0.869 mmol). The vials are flushed with N2 before anhydrous dimethylformamide (5.5 mL) is added and then sealed. Each reaction is heated in the CEM Discover microwave at 185° C. for 1 hr. The 2 reactions are combined diluted with water and extracted with 3 portions of dichloromethane. The combined dichloromethane layers are washed with 2 portions of 1 M aqueous sodium hydroxide, dried over magnesium sulfate and evaporated to give a dark oil. The crude product is purified by flash chromatography on a 5-gram silica gel cartridge by elution with dichloromethane:ethyl acetate (1:1). Fractions containing the product are combined. The solvent evaporated, and the residue is further purified by flash chromatography on a 5-gram silica gel cartridge by elution with dichloromethane:ethyl acetate (3:1, increasing to 2:1). Clean fractions containing the product are combined and evaporated to give 3-ethyl-5-(imidazol-1-yl)-2-methoxy-6-methyl-pyridine (53 mg, 14% yield) as a yellow oil. MS: m/e=218 (M+H); 1H NMR (300 MHz, CDCl3, δ ppm): 7.54 (1H, s) 7.22 (1H, s), 7.21 (1H, s), 7.00 (1H, s), 3.98 (3H, s), 2.59 (2H, q), 2.25 (3H, s), 1.10 (3H, t).

후처리

  1. customThe vials are flushed with N2 before anhydrous dimethylformamide (5.5 mL)
  2. additionis added
  3. customsealed
  4. additionThe 2 reactions are combined diluted with water
  5. extractionextracted with 3 portions of dichloromethane
  6. washThe combined dichloromethane layers are washed with 2 portions of 1 M aqueous sodium hydroxide
  7. dry with materialdried over magnesium sulfate
  8. customevaporated
  9. customto give a dark oil
  10. customThe crude product is purified by flash chromatography on a 5-gram silica gel cartridge by elution with dichloromethane:ethyl acetate (1:1)
  11. additionFractions containing the product
  12. customThe solvent evaporated
  13. customthe residue is further purified by flash chromatography on a 5-gram silica gel cartridge by elution with dichloromethane:ethyl acetate (3:1, increasing to 2:1)
  14. additionClean fractions containing the product
  15. customevaporated

출처 및 근거

ORD 기록
ord-b53e918b7d6a46f88535313e40c55e4d
출처 데이터셋
uspto-grants-2012_05
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08173682B2

반응 노트

이 페이지에서참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트